
Bernstein SocGen Group has raised its price target for Humana to $515, reflecting confidence in the health insurer's strong performance. Humana shares have surged 80.1% year-to-date and recently hit a 52-week high of $462.87. The company plans to launch a national Gold Card program on December 1 to simplify prior authorization processes and help patients access care faster. Despite a recent slight share price dip, Humana's market outlook remains positive following consistent earnings beats and operational improvements.
Following Bernstein SocGen Group's raised price target for Humana, the stock trades at USD 443.18 on Pluang as of Nov 18, 2026 00:52 WIB, down 3.89% for the day. The share price remains close to its 52-week high of USD 461.12, with a market cap of $55.40 billion. Investors on Pluang show full buying interest, with 100% of order activity on the buy side and a typical hold time of 51 days.